Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 06:00
CGTN: TCM continues to play significant role in treating COVID-19 2023-01-11 23:09
Bio4t2 announces first patient infused with CAR-T targeting solid tumors 2023-01-11 09:00
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval 2023-01-11 09:00
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-2) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes 2023-01-11 00:00
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer 2023-01-10 21:05
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors 2023-01-10 21:05
Renexxion Announces Opening of Investigational New Drug (IND) Application for Naronapride for the Treatment of Gastrointestinal Dysmotility in Cystic Fibrosis Patients 2023-01-10 21:00
Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2- Breast Cancer 2023-01-10 21:00
CSafe Bolsters Its Digital Ecosystem Launching TracSafe Data Loggers and CSafe Connect Portal 2023-01-10 20:00
Sarah Otten Joins Medison Pharma as VP, GM Americas Region 2023-01-10 19:54
Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report 2023-01-10 16:00
Bangkok Dusit Medical Services extends partnership with CNN to explore global health issues 2023-01-10 11:24
Insilico Medicine Announces Positive Topline Results of the New Zealand Phase I Trial of INS018_055, an AI-Designed Drug for an AI-Discovered Target 2023-01-10 05:00
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes 2023-01-10 00:00
Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong 2023-01-09 18:57
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering 2023-01-06 15:05
Innovent Announces the National Medical Products Administration in China Has Accepted and Granted Priority Review Designation to the New Drug Application for Parsaclisib (PI3Kδ inhibitor) for the Treatment of Relapsed or Refractory Follicular Lymphoma 2023-01-06 12:22
Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 23:30
AMR Action Fund Announces Investment in BioVersys AG 2023-01-05 20:00
1 48 49 50 51 52 230